UTILITY VALUES FOR HEALTH STATES ASSOCIATED WITH DUCHENNE MUSCULAR DYSTROPHY: A SYSTEMATIC REVIEW

被引：0
|
作者：
Szabo, S. [1 ]
Audhya, I. F. [2 ]
Malone, D. C. [3 ]
Feeny, D. [4 ]
Gooch, K. [2 ]
机构：
[1] Broadst Hlth Econ & Outcomes Res, Vancouver, BC, Canada
[2] Sarepta Therapeut, Cambridge, MA USA
[3] Univ Arizona, Tucson, AZ USA
[4] McMaster Univ, Hamilton, ON, Canada
来源：
VALUE IN HEALTH | 2019年 / 22卷
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PRO67
引用
收藏
页码：S853 / S853
页数：1
相关论文
共 50 条
  • [1] UTILITY VALUES FOR HEALTH STATES ASSOCIATED WITH DUCHENNE MUSCULAR DYSTROPHY: A SYSTEMATIC REVIEW
    Szabo, Shelagh M.
    Audhya, Ivana
    Malone, Daniel
    Feeny, David
    Gooch, Katherine L.
    MEDICAL DECISION MAKING, 2020, 40 (01) : E197 - E198
  • [2] Characterizing health state utilities associated with Duchenne muscular dystrophy: a systematic review
    Shelagh M. Szabo
    Ivana F. Audhya
    Daniel C. Malone
    David Feeny
    Katherine L. Gooch
    Quality of Life Research, 2020, 29 : 593 - 605
  • [3] Characterizing health state utilities associated with Duchenne muscular dystrophy: a systematic review
    Szabo, Shelagh M.
    Audhya, Ivana F.
    Malone, Daniel C.
    Feeny, David
    Gooch, Katherine L.
    QUALITY OF LIFE RESEARCH, 2020, 29 (03) : 593 - 605
  • [4] TIME TRADE-OFF UTILITY VALUES FOR HEALTH STATES CHARACTERIZING PROGRESSIVE MUSCULAR DEGENERATION IN DUCHENNE MUSCULAR DYSTROPHY (DMD)
    Audhya, Filipovic, I
    Szabo, S.
    Bever, A. E.
    Malone, D. C.
    Feeny, D.
    Neumann, P., I
    Bolatova, T.
    Iannaccone, S. T.
    Gooch, K. L.
    VALUE IN HEALTH, 2022, 25 (07) : S574 - S574
  • [5] Factors Associated with Respiratory Health and Function in Duchenne Muscular Dystrophy: A Systematic Review and Evidence Grading
    Landfeldt, E.
    Aleman, A.
    Abner, S.
    Zhang, R.
    Werner, C.
    Tomazos, I.
    Lochmueller, H.
    Quinlivan, R. M.
    JOURNAL OF NEUROMUSCULAR DISEASES, 2024, 11 (01) : 25 - 57
  • [6] HEALTH STATE UTILITY VALUES FOR STAGES OF FUNCTIONAL DECLINE IN DUCHENNE MUSCULAR DYSTROPHY: AN INTERNATIONAL STUDY
    Crossnohere, N.
    Fischer, R.
    Bridges, J.
    VALUE IN HEALTH, 2020, 23 : S344 - S344
  • [7] SYSTEMATIC LITERATURE REVIEWS OF HEALTH-STATE UTILITY VALUES, COSTS, AND HEALTHCARE RESOURCE USE IN DUCHENNE MUSCULAR DYSTROPHY (DMD)
    Yip, C. Y.
    Stewart, D.
    Shapiro, H.
    Macmillan, T.
    Kemadjou, Ngonga E.
    VALUE IN HEALTH, 2024, 27 (12) : S355 - S355
  • [8] Duchenne muscular dystrophy and caregiver burden: a systematic review
    Landfeldt, Erik
    Edstroem, Josefin
    Buccella, Filippo
    Kirschner, Janbernd
    Lochmueller, Hanns
    DEVELOPMENTAL MEDICINE AND CHILD NEUROLOGY, 2018, 60 (10): : 987 - +
  • [9] Improvements in health status and utility associated with ataluren for the treatment of nonsense mutation Duchenne muscular dystrophy
    Landfeldt, Erik
    Lindberg, Christopher
    Sejersen, Thomas
    MUSCLE & NERVE, 2020, 61 (03) : 363 - 368
  • [10] A systematic review of pharmacologic therapies for the cardiomyopathy of Duchenne muscular dystrophy
    Kipke, Jasmine
    Birnkrant, David J.
    Jin, Justin B.
    Aneja, Ashish
    Bahler, Robert C.
    PEDIATRIC PULMONOLOGY, 2021, 56 (04) : 782 - 795
12345